GILLIS STEVEN enters TAKEDA PHARMACEUTICAL CO LTD with 25.56K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001628280-26-019014
Director
Since Mar 2026
25.56K
Baseline shares
100% direct
25.56K
Direct ownership
2 positions
5.88K
Derivative underlying
4 instruments
2
Security positions
All direct
Non-Derivative Holdings2
American Depositary Shares
DirectShares owned15.86K
Ordinary Shares
DirectShares owned9.70K
Total
25.56K direct25.56K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Shares | 15.86K | Direct |
| Ordinary Shares | 9.70K | Direct |
| Total | 25.56K | 25.56K direct |
Derivative Holdings4
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
1.19K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
1.18K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Cash Settled Retirement Award
DirectUnderlying security
Ordinary Shares
Underlying shares
2.36K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Tax Obligation Award
DirectUnderlying security
Ordinary Shares
Underlying shares
1.15K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
5.88K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Tax Obligation Award Direct | Ordinary Shares | — | — | 1.19K | N/A | |
| Tax Obligation Award Direct | Ordinary Shares | — | — | 1.18K | N/A | |
| Cash Settled Retirement Award Direct | Ordinary Shares | — | — | 2.36K | N/A | |
| Tax Obligation Award Direct | Ordinary Shares | — | — | 1.15K | N/A | |
| Total | 5.88K | 0.00 | ||||